Gene · 8321
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The mechanisms crosstalk and therapeutic opportunities between ferroptosis and ovary diseases. | Front Endocrinol (Lausanne) | 2023 | 37564979 | PubTator, text mining | PubMed |
| Defective EMC1 drives abnormal retinal angiogenesis via Wnt/β-catenin signaling and may be associated with the pathogenesis of familial exudative vitreoretinopathy. | Genes Dis | 2023 | 37554197 | PubTator, text mining | PubMed |
| Identifying the critical state of cancers by single-sample Markov flow entropy. | PeerJ | 2023 | 37520244 | PubTator, text mining | PubMed |
| Pathway selectivity in Frizzleds is achieved by conserved micro-switches defining pathway-determining, active conformations. | Nat Commun | 2023 | 37516754 | PubTator, text mining | PubMed |
| Wnt/β-Catenin Signaling Activation Induces Differentiation in Human Limbal Epithelial Stem Cells Cultured Ex Vivo. | Biomedicines | 2023 | 37509479 | PubTator, text mining | PubMed |
| Entire Expressed Peripheral Blood Transcriptome in Pediatric Severe Malarial Anemia. | Res Sq | 2023 | 37503086 | PubTator, text mining | PubMed |
| Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications. | Front Cell Dev Biol | 2023 | 37492224 | PubTator, text mining | PubMed |
| Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR/AKT and Wnt/β-catenin signaling. | Hepatol Commun | 2023 | 37486965 | PubTator, text mining | PubMed |
| Sequence variants contributing to dysregulated inflammatory responses across keratoconic cone surface in adolescent patients with keratoconus. | Front Immunol | 2023 | 37483635 | PubTator, text mining | PubMed |
| Gαq Signaling Activates β-Catenin-Dependent Gene Transcription | Iran Biomed J | 2023 | 37481708 | PubTator, text mining | PubMed |
| Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer. | Cell Biosci | 2023 | 37480151 | PubTator, text mining | PubMed |
| The mechanisms of class 1A PI3K and Wnt/β-catenin coupled signaling in breast cancer. | Biochem Soc Trans | 2023 | 37471270 | PubTator, text mining | PubMed |
| Mutant APC reshapes Wnt signaling plasma membrane nanodomains by altering cholesterol levels via oncogenic β-catenin. | Nat Commun | 2023 | 37468468 | PubTator, text mining | PubMed |
| Apoptosis of Kinetin Riboside in Colorectal Cancer Cells Occurs by Promoting β-Catenin Degradation. | J Microbiol Biotechnol | 2023 | 37463866 | PubTator, text mining | PubMed |
| Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells. | Int J Mol Sci | 2023 | 37445628 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine RNA modification in gastric cancer. | Cell Death Discov | 2023 | 37443100 | PubTator, text mining | PubMed |
| Human beta defensin-3 mediated activation of β-catenin during human respiratory syncytial virus infection: interaction of HBD3 with LDL receptor-related protein 5. | Front Microbiol | 2023 | 37426017 | PubTator, text mining | PubMed |
| Encapsulation of MCC950 in Liposomes Decorated with Anti-Frizzled 1 Improves Drug Bioavailability and Effectiveness in Fatty Liver Disease. | ACS Appl Mater Interfaces | 2023 | 37417887 | PubTator, text mining | PubMed |
| Novel Frizzled-specific antibody-based Wnt mimetics and Wnt superagonists selectively activate WNT/β-catenin signaling in target tissues. | Cell Chem Biol | 2023 | 37413985 | PubTator, text mining | PubMed |
| DNA methylation biomarkers distinguishing early-stage prostate cancer from benign prostatic hyperplasia. | Prostate Int | 2023 | 37409096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8321/papers?page=8